Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

Similar articles for PubMed (Select 24259266)

1.

KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.

Kohonen-Corish MR, Tseung J, Chan C, Currey N, Dent OF, Clarke S, Bokey L, Chapuis PH.

Int J Cancer. 2014 Jun 15;134(12):2820-8. doi: 10.1002/ijc.28619. Epub 2013 Dec 6.

PMID:
24259266
2.

Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy.

Mitsuhashi K, Yamamoto I, Kurihara H, Kanno S, Ito M, Igarashi H, Ishigami K, Sukawa Y, Tachibana M, Takahashi H, Tokino T, Maruyama R, Suzuki H, Imai K, Shinomura Y, Yamamoto H, Nosho K.

Oncotarget. 2015 Jun 17. [Epub ahead of print]

3.

Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations.

Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD.

Mol Cancer Res. 2015 Jun 2. pii: molcanres.0203.2015. [Epub ahead of print]

PMID:
26037647
4.

[Genetic aspects of pancreatic cancer].

Grigor'eva IN, Efimova OV, Suvorova TS, Tov NL.

Eksp Klin Gastroenterol. 2014;(10):70-6. Review. Russian.

PMID:
25911935
5.

Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.

Berg M, Nordgaard O, Kørner H, Oltedal S, Smaaland R, Søreide JA, Søreide K.

PLoS One. 2015 Apr 16;10(4):e0122391. doi: 10.1371/journal.pone.0122391. eCollection 2015.

6.

BRAF and CDKN2A mutations in secondary high-grade glioma.

Boughton B.

Lancet Oncol. 2015 May;16(5):e201. doi: 10.1016/S1470-2045(15)70145-2. Epub 2015 Mar 27. No abstract available.

PMID:
25818616
7.

Detection of Tumor Suppressor Genes in Cancer Development by a Novel shRNA-Based Method.

von Burstin J, Diersch S, Schneider G, Reichert M, Rustgi AK, Schmid RM.

Mol Cancer Res. 2015 May;13(5):863-9. doi: 10.1158/1541-7786.MCR-14-0709. Epub 2015 Feb 27.

PMID:
25724428
8.

Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.

Pilozzi E, Maresca C, Duranti E, Giustiniani MC, Catalanotto C, Lucarelli M, Cogoni C, Ferri M, Ruco L, Zardo G.

Am J Clin Pathol. 2015 Mar;143(3):374-84. doi: 10.1309/AJCPNOC55IOLXFUD.

PMID:
25696795
9.

Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Bae JM, Lee TH, Cho NY, Kim TY, Kang GH.

World J Gastroenterol. 2015 Feb 7;21(5):1457-67. doi: 10.3748/wjg.v21.i5.1457.

10.

[Investigation of a family with porokeratosis combined with rectal cancer].

Yu J, Xu J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Feb;32(1):140. doi: 10.3760/cma.j.issn.1003-9406.2015.01.036. Chinese. No abstract available.

PMID:
25636117
11.

Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.

Laskar RS, Ghosh SK, Talukdar FR.

Mol Carcinog. 2014 Nov 21. doi: 10.1002/mc.22250. [Epub ahead of print]

PMID:
25418895
12.

MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer.

Renaud F, Vincent A, Mariette C, Crépin M, Stechly L, Truant S, Copin MC, Porchet N, Leteurtre E, Van Seuningen I, Buisine MP.

Int J Cancer. 2015 Jun 15;136(12):2811-21. doi: 10.1002/ijc.29342. Epub 2014 Dec 4.

PMID:
25403854
13.

The promise of methylation on beads for cancer detection and treatment.

Guzzetta AA, Pisanic Ii TR, Sharma P, Yi JM, Stark A, Wang TH, Ahuja N.

Expert Rev Mol Diagn. 2014 Sep;14(7):845-52. doi: 10.1586/14737159.2014.943665. Review.

14.

Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.

Wiland HO 4th, Shadrach B, Allende D, Carver P, Goldblum JR, Liu X, Patil DT, Rybicki LA, Pai RK.

Am J Surg Pathol. 2014 Sep;38(9):1290-7. doi: 10.1097/PAS.0000000000000253.

PMID:
25127095
15.

DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence.

Benard A, Zeestraten EC, Goossens-Beumer IJ, Putter H, van de Velde CJ, Hoon DS, Kuppen PJ.

Apoptosis. 2014 Nov;19(11):1581-93. doi: 10.1007/s10495-014-1022-z.

PMID:
25064172
16.

Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation.

Leong KJ, Beggs A, James J, Morton DG, Matthews GM, Bach SP.

Br J Surg. 2014 Sep;101(10):1299-309. doi: 10.1002/bjs.9571. Epub 2014 Jul 23.

17.

Proteogenomic characterization of human colon and rectal cancer.

Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ, Shaddox KF, Kim S, Davies SR, Wang S, Wang P, Kinsinger CR, Rivers RC, Rodriguez H, Townsend RR, Ellis MJ, Carr SA, Tabb DL, Coffey RJ, Slebos RJ, Liebler DC; NCI CPTAC.

Nature. 2014 Sep 18;513(7518):382-7. doi: 10.1038/nature13438. Epub 2014 Jul 20.

18.

SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.

Li T, Liao X, Lochhead P, Morikawa T, Yamauchi M, Nishihara R, Inamura K, Kim SA, Mima K, Sukawa Y, Kuchiba A, Imamura Y, Baba Y, Shima K, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S, Qian ZR.

Ann Surg Oncol. 2014 Dec;21(13):4164-73. doi: 10.1245/s10434-014-3888-y. Epub 2014 Jul 15.

PMID:
25023548
19.

Jejunal Cancer with WRN Mutation Identified from Next-Generation Sequencing: A Case Study and Minireview.

Chang C, Shiah HS, Hsu NY, Huang HY, Chu JS, Yen Y.

Case Rep Surg. 2014;2014:126924. doi: 10.1155/2014/126924. Epub 2014 Jun 15.

20.

The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.

Lin CC, Lin JK, Lin TC, Chen WS, Yang SH, Wang HS, Lan YT, Jiang JK, Yang MH, Chang SC.

J Surg Oncol. 2014 Sep;110(4):451-7. doi: 10.1002/jso.23675. Epub 2014 Jun 25.

PMID:
24964758
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk